Explores sensor systems and algorithms for monitoring vital signs in overweight and obese individuals, emphasizing technical advancements and clinical validations.
Explores Alzheimer's disease, anxiety, pain, and the renin-angiotensin system, including the development of the first renin inhibitor for clinical treatment.
